AN2 Therapeutics, Inc. (ANTX) Live Share Price, Invest From India

AN2 Therapeutics, Inc. Stock Performance

as on September 26, 2026 at 2:15 pm IST

Day's Low
Day's High
$4.71
Day's Price Range
$4.93
$4.88
3.48%
Downside
1.02%
Upside
52 Week's Low
52 Week's High
$1.00
52-Week Price Range
$7.19
$4.88
79.51%
Downside
47.34%
Upside

AN2 Therapeutics, Inc. share price movements today

Previous Close: $4.89
Open: $4.90
Volume: 203.5K
Market Cap: $182.3M
Day's Low - High: $4.71 - $4.93
52 Week Low - High: $1.00 - $7.19

AN2 Therapeutics, Inc. Historical Returns

1 Month Return: -11.75 %
3 Month Return: -6.15 %
1 Year Return: + 290.4 %
3 Year Return: -67.94 %
5 Year Return: 0 %

AN2 Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check AN2 Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$182.3M

EPS (TTM)

-1.07

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.57

Industry PE ratio

-2.65

PEG Ratio

-0.3203868469408864

EBITDA

-37.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-53.52%

AN2 Therapeutics, Inc. Stock Valuation

Track how AN2 Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

AN2 Therapeutics, Inc. in the last 5 years

Overview
Trends

Lowest (-13.40x)

December 31, 2021

Industry (-2.65x)

December 31, 2025

Today (-0.98x)

December 31, 2025

Highest (-0.80x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.98x

AN2 Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of AN2 Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
AN2 Therapeutics, Inc.	Buy	$182.3M	NA	-4.57	0.00%	0.00%
Moderna	Neutral	$77.8B	-53.76%	-24.41	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.4B	186.58%	30.16	86.04%	0.00%
Regeneron	Buy	$82.8B	23.34%	19.01	84.86%	0.46%

Stock Returns calculator for AN2 Therapeutics, Inc. Stock including INR - Dollar returns

The AN2 Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

AN2 Therapeutics, Inc. investment value today

Current value as on today

₹4,21,384

Returns

₹3,21,384

(+321.38%)

Returns from AN2 Therapeutics, Inc. Stock

₹2,90,400 (+290.4%)

Dollar Impact

₹30,984 (+30.98%)

Analyst Recommendation on AN2 Therapeutics, Inc. Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for AN2 Therapeutics, Inc.. Average target price of $9

AN2 Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on AN2 Therapeutics, Inc..

What analysts predicted

45.78%UPSIDE

Target Price

Current Price

$4.88

Analyzed by

1 Analysts

High

Target

$9.00

Low

AN2 Therapeutics, Inc. target price $9, a slight upside of 45.78% compared to current price of $4.88. According to 1 analysts rating.

Indian Investors' Interest in AN2 Therapeutics, Inc. Stock

Search interest for AN2 Therapeutics, Inc. Stock has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 27, 2026 to September 26, 2026

Change:-82% versus previous 30 day period

AN2 Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-18	-15	-14	-8	-11	-7	-10	-9	-10	-8
EBITDA	-16	10	-11	-	-10	-6	-9	-10	-10	-8
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	25	-	8	-	-	-	-	-	-
Income Before Tax	-16	-14	-12	-7	-10	-6	-9	-8	-10	-8
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-16	-14	-12	-7	-10	-6	-9	-8	-10	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

AN2 Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	0	-	-	-
Operating Income	-31	-7	-21	-42	-69	-54	-38
EBITDA	-	-6	-21	-40	4	3	-35
Interest Expense	-	-	-	0	-	-	-
Depreciation	31	7	-	0	69	54	-
Income Before Tax	-33	-13	-21	-40	-64	-51	-35
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-33	-13	-21	-40	-64	-51	-35
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

AN2 Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-16	-14	-12	-7	-10	-6	-9	-8	-10	-8
Operating Cash Flow	-17	-14	-12	-5	-10	-7	-6	-5	-12	-6
Investing Cash Flow	26	16	18	-6	9	5	6	7	8	-3
Financing Cash Flow	0	-	0	-	0	-	0	-	37	1
Change in Cash	9	2	6	-12	-1	-1	0	1	33	-9

AN2 Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-13	-21	-40	-64	-51	-35
Operating Cash Flow	-2	-5	-20	-33	-53	-49	-29
Investing Cash Flow	-	-	-50	-21	-43	54	28
Financing Cash Flow	8	3	78	70	84	0	0
Change in Cash	5	-1	8	15	-11	5	-1

Mutual Funds that own AN2 Therapeutics, Inc. Stock

Check out the Mutual Funds with significant holdings in AN2 Therapeutics, Inc..

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	2.611558%	985504
Fidelity Concord Street Trust	0.549983%	207543
Bridgeway Funds, Inc.	0.156348%	59000
VANGUARD VALLEY FORGE FUNDS	0.033901%	12793
VANGUARD INSTITUTIONAL INDEX FUNDS	0.033869%	12781

See all

Global Institutional Holdings in AN2 Therapeutics, Inc.

Funds	Holdings
Vanguard	3.69%
iShares	2.65%
VANGUARD INDEX FUNDS	2.61%
Michael Rockefeller	1.22%
Fidelity Concord Street Trust	0.55%

See all

Insights on AN2 Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, ANTX stock has moved up by 290.4%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 102.7% return, outperforming this stock by 170.6%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 421.7%

About AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease. This enterprise was established in 2017 and operates from its headquarters situated in Menlo Park, California.

Organisation	AN2 Therapeutics, Inc.
Headquarters	1800 El Camino Real, Menlo Park, CA, 94025, US
Industry	Biotechnology
CEO	Eric E. Easom
E-voting on shares	Click here to vote

Key Management of AN2 Therapeutics, Inc.

Name	Title
Dr. Sanjay Chanda Ph.D.	Chief Development Officer
Dr. Cameron Trenor III	Chief Medical Officer
Mr. Eric E. Easom	Co-Founder, CEO, President & Chairman of the Board
Mr. Joseph S. Zakrzewski	Co-Founder & Independent Director
Mr. Joshua M. Eizen J.D.	Chief Legal Officer, COO & Corporate Secretary
Dr. George Harrison Talbot FACP, M.D.	Co-Founder & Senior Clinical Advisor
Dr. Michael R. K. Alley Ph.D.	Co-Founder, Senior VP of Research Fellow & Head of Biology
Ms. Sarah Williams	Vice President of Controller & Principal Accounting Officer
Ms. Lucy O. Day CPA	CFO, & Principal Financial Officer
Mr. Vince Hernandez	Senior VP of Research & Head of Chemistry

FAQs

What is AN2 Therapeutics, Inc. share price today?

AN2 Therapeutics, Inc. share price today is $4.88 as on September 26, 2026 at 8:45 am IST at the close of the market. AN2 Therapeutics, Inc. share today touched a day high of $4.93 and a low of $4.71.

What is the 52 week high and 52 week low for AN2 Therapeutics, Inc. share?

AN2 Therapeutics, Inc. share touched a 52 week high of $7.19 on August 12, 2026 and a 52 week low of $1.00 on February 19, 2026. AN2 Therapeutics, Inc. stock price today i.e. September 26, 2026 at 8:45 am IST is closed at $4.88,which is 32.13% down from its 52 week high and 388.00% up from its 52 week low.

What is AN2 Therapeutics, Inc.'s market capitalisation today?

AN2 Therapeutics, Inc. market capitalisation is $0.00T as on September 26, 2026 at 8:45 am IST.

How to invest in AN2 Therapeutics, Inc. Stock (ANTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for AN2 Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AN2 Therapeutics, Inc. Shares that will get you 0.3074 shares as per AN2 Therapeutics, Inc. share price of $4.88 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy AN2 Therapeutics, Inc. Stock (ANTX) from India?

Indian investors can start investing in AN2 Therapeutics, Inc. (ANTX) shares with as little as ₹95.8125 or $1 (as of September 26, 2026 at 12:45 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in AN2 Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 26, 2026 at 12:45 pm IST). Based on AN2 Therapeutics, Inc. share’s latest price of $4.88 as on September 26, 2026 at 8:45 am IST, you will get 2.0492 shares of AN2 Therapeutics, Inc.. Learn more about fractional shares .